ZOTTA, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 431
EU - Europa 215
AS - Asia 65
Totale 711
Nazione #
US - Stati Uniti d'America 430
IT - Italia 70
CN - Cina 45
SE - Svezia 42
IE - Irlanda 34
UA - Ucraina 27
SG - Singapore 11
DE - Germania 10
ES - Italia 8
FR - Francia 8
GB - Regno Unito 5
BE - Belgio 3
HK - Hong Kong 3
KR - Corea 3
PL - Polonia 2
RO - Romania 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BY - Bielorussia 1
CA - Canada 1
NL - Olanda 1
NO - Norvegia 1
Totale 711
Città #
Chandler 115
Ashburn 54
Dublin 34
Beijing 25
Jacksonville 25
Torino 25
Nyköping 23
Fairfield 19
Wilmington 10
Seattle 9
Singapore 9
Boston 8
San Mateo 8
Woodbridge 8
Fremont 7
Houston 6
Medford 6
Cambridge 5
Vigo 5
Ann Arbor 4
Milan 4
Redwood City 4
Aosta 3
Brussels 3
Central District 3
Guangzhou 3
Hefei 3
Kunming 3
Princeton 3
Rome 3
Santiago De Compostela 3
Baotou 2
Dearborn 2
Dong Ket 2
Feltre 2
Genova 2
Los Angeles 2
Nanjing 2
Rochester 2
Seoul 2
Akron 1
Albuquerque 1
Bari 1
Berlin 1
Boardman 1
Bognor Regis 1
Changsha 1
Edinburgh 1
Gunzenhausen 1
Göttingen 1
Hachenburg 1
Hangzhou 1
Ithaca 1
Moncalieri 1
Mountain View 1
Nanchang 1
Napoli 1
North Charleston 1
Norwalk 1
Oslo 1
San Diego 1
Santa Ana Heights 1
Santa Clara 1
Sofia 1
Toronto 1
Turin 1
Valenza 1
Xian 1
Zevenhuizen 1
Zhengzhou 1
Ürümqi 1
Totale 489
Nome #
KRIT1 Deficiency Promotes Aortic Endothelial Dysfunction 108
KRIT1 loss of function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: implication for Cerebral Cavernous Malformation disease 81
KRIT1/CCM1 Loss-of-function Mutations Impair Anti-glycative and Anti-oxidant Systems Worsening High Fructose Diet-induced Hepatic Dismetabolism 77
Identification of risk factors and biomarkers of diagnostic and prognostic value associated with clinical progression and severity of cerebral cavernous malformations 75
Multifunctional platinum@bsa-rapamycin nanocarriers for combinatorial therapy of cerebral cavernous malformation disease 73
KRIT1 loss-mediated upregulation of NOX1 in stromal cells promotes paracrine pro-angiogenic responses 71
KRIT1/CCM1 loss-of-function affects sphingolipid metabolism inducing hepatosteatosis and predisposing to liver fibrosis and insulin-resistance 63
KRIT1/CCM1 loss-of-function impairs advanced glycation endproducts receptors and detoxification and worsens fructose diet-induced hepatic dysmetabolism 63
KRIT1 loss-of-function induces a sustained Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: implication for Cerebral Cavernous Malformation disease 62
Production of KRIT1-knockout and KRIT1-knockin Mouse Embryonic Fibroblasts as Cellular Models of CCM Disease 61
Totale 734
Categoria #
all - tutte 2.970
article - articoli 0
book - libri 0
conference - conferenze 2.194
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.164


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020112 0 0 0 5 1 2 27 18 27 9 11 12
2020/2021120 14 12 20 3 12 5 6 7 18 6 12 5
2021/2022155 7 0 3 1 20 5 15 17 1 5 41 40
2022/2023234 19 28 10 47 8 54 12 22 19 3 10 2
2023/2024100 13 21 0 4 4 7 0 35 1 5 1 9
2024/202513 1 8 4 0 0 0 0 0 0 0 0 0
Totale 734